Form 4: Semler Scientific CEO Exercises Options, Adjusts Holdings

Semler Scientific's CEO, Douglas Murphy-Chutorian, exercised stock options, sold shares to cover costs, and transferred remaining direct holdings to a family trust.

Summary

• Douglas Murphy-Chutorian, CEO, interim CFO, and Director of Semler Scientific, Inc. (SMLR), reported transactions on November 17, 2025.
• Exercised 125,000 stock options at an exercise price of $2.23 per share.
• Sold 57,669 shares of common stock at a weighted average price of $20.09 per share (ranging from $19.57 to $20.56) to cover the exercise price and withholding taxes.
• Sold an additional 12,737 shares of common stock at a weighted average price of $20.73 per share (ranging from $20.57 to $21.26) for the same purpose.
• Transferred 54,594 shares of common stock from direct ownership to a family trust, with no monetary consideration ($0 price).
• Following these transactions, direct beneficial ownership of common stock is 0 shares.
• Indirect beneficial ownership through the family trust is 241,303 shares, over which Dr. Murphy-Chutorian shares voting and investment power with his spouse.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the option exercise is a positive signal, the subsequent sales, even for tax purposes, can be viewed with caution. The overall beneficial ownership remains substantial through a family trust.

Positives

• The exercise of 125,000 stock options indicates a degree of confidence in the company's future by the CEO.
• The CEO maintains a substantial indirect beneficial ownership of 241,303 shares through a family trust.

Negatives

• The sale of 70,406 shares (57,669 + 12,737) by an insider, even if for tax and exercise cost coverage, can be perceived negatively by the market.

Risks

• Insider selling, regardless of the stated reason, can sometimes lead to negative market sentiment or speculation about the company's near-term prospects.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing reports an insider transaction and does not provide information directly related to broader industry trends or competitive landscape.

Related Party Transactions

• Transfer of 54,594 shares to a family trust where the reporting person is a co-Trustee with his spouse, sharing voting and investment power.

Stakeholder Impact

• Shareholders may interpret the insider sales as a mixed signal, balancing the confidence shown by option exercise against the reduction in direct holdings.
• The transfer to a family trust indicates a long-term holding strategy for a portion of the CEO's equity.

Key Dates

Recommendation

The insider transactions present a mixed signal. The exercise of options suggests confidence, but the subsequent sales, while common for tax and exercise cost coverage, represent a reduction in direct holdings. The significant indirect ownership through a family trust indicates continued long-term interest. Without additional company-specific news or broader market context, a 'hold' recommendation is appropriate as the transactions do not provide a strong directional signal for immediate investment action.

Keywords

Semler Scientific, SMLR, Insider Transaction, Form 4, Stock Options, Beneficial Ownership, CEO, Equity Sales, Family Trust